Proactive Investors - Run By Investors For Investors

Directa Plus PLC gets G+ green light from toxicity testing firm

This latest decision complements previous tests conducted by Complife (then operating as Farcoderm) on all of Directa Plus's graphene-based materials, which were certified as safe for human contact
Skin irritation
It's what you might call a rash decision, but in a positive way

Directa Plus Plc (LON:DCTA) said its Graphene Plus (G+) membrane and G+ printed fabrics have received international certification from Complife Italia.

Complife, an independent toxicity testing organisation, confirmed that the materials do not cause any irritation to human skin.

READ: Directa Plus inks high performance textiles deal with Alfredo Grassi

"We are pleased to have our G+ membrane and printed fabrics proven to be non-irritating to human skin. This adds to the certification we received last year that our graphene-based materials are non-toxic and non-cytotoxic,” said Giulio Cesareo, chief ececutive officer of Directa Plus.

“With our Graphene Plus textiles, our customers can truly differentiate their products as innovative, performance-enhancing and comfortable to wear. We have always prided ourselves on the safety and environmental credentials of our production processes and graphene-based products, and this new certification further represents that commitment," he added.

WATCH: Directa Plus hires heavy-hitting new head of sales

Shares in Directa Plus were up 0.5% in early trading.

View full DCTA profile View Profile

Directa Plus PLC Timeline

Related Articles

Italian police
October 23 2018
Founded 12 years ago, its aim is to design a system to produce graphene in a “sustainable, simple and a scalable way”

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use